ARTICLE | Top Story
Azulfidine approved for children
August 22, 2000 7:00 AM UTC
Pharmacia (PHA) received FDA approval to market Azulfidine EN-tabs (sulfasalazine) delayed release tablets to treat rheumatoid arthritis (RA) involving five or more diseased joints in children from 6 ...